Latest Insider Transactions at Kairos Pharma, Ltd. (KAPA)
This section provides a real-time view of insider transactions for Kairos Pharma, Ltd. (KAPA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Kairos Pharma, LTD. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Kairos Pharma, LTD.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2024
|
Ramachandran Murali VP of Research and Development |
BUY
Open market or private purchase
|
Direct |
200
+0.15%
|
$200
$1.59 P/Share
|
|
Nov 22
2024
|
Doug Samuelson Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+3.95%
|
$2,500
$1.5 P/Share
|
|
Nov 20
2024
|
John S Yu CEO and Chairman |
BUY
Open market or private purchase
|
Direct |
4,000
+0.07%
|
$4,000
$1.44 P/Share
|